HIV mutation literature information.


  Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study.
 PMID: 34694878       2022       Antimicrobial agents and chemotherapy
Table: G190A


  Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
 PMID: 33369017       2021       HIV medicine
Abstract: Using the 2% detection threshold, individual DRMs with the highest prevalence were: PI M46IL (5.5%), RT K103NS (3.5%), RT G190ASE (3.1%), T215ISCDVEN (2.5%), RT M41L (2.2%), RT K219QENR (1.7%) and PI D30N (1.6%).
Discussion: Of the most frequent NNRTI DRMs, G190ASE occurred predominately as minor variants while


  Phylogenetic and Drug-Resistance Analysis of HIV-1 Sequences From an Extensive Paediatric HIV-1 Outbreak in Larkana, Pakistan.
 PMID: 34484134       2021       Frontiers in microbiology
Table: G190A


  Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
 PMID: 34064774       2021       Viruses
Result: Four SDRMs increased in prevalence in RTI-naive persons including K103N, V106M, and G190A/E while L100I decreased in prevalence among RTI-naive persons.


  HIV-1 subtypes and drug resistance in children during antiretroviral therapy in Brazil.
 PMID: 33788308       2021       Journal of medical virology
Abstract: The most common primary mutations found were M184V (29.5%), K103N (25%), M41L (9.8%), T215Y (8.3%), and G190A (8.3%).


  Increase in HIV-1-transmitted drug resistance among ART-naive youths at the China-Myanmar border during 2009 ~ 2017.
 PMID: 33478415       2021       BMC infectious diseases
Table: G190A


  Determination of reverse transcriptase inhibitor resistance mutations in HIV-1 infected children in Cote d'Ivoire.
 PMID: 33170745       2021       Genome
Abstract: Frequently encountered resistance mutations were for NRTIs: M184V (88%), TAMs (67%), T215F/I/V/Y (33%), and L74I/V (24%); for NNRTIs: K103N/S (74%), P225H (26%), and G190A/E/Q (24%).


  Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina.
 PMID: 34085506       2021       Revista espanola de quimioterapia
Abstract: Predominant NNRTI RAMs were K103N (n=4; 10%) and G190A/E/S (n=3; 7.5%).
Result: Predominant NNRTI RAMs were K103N (n=4; 10%) and G190A/E/S (n=3; 7.5%), which confer high level resistance to efavirenz and nevirapine and intermediate to rilpivirine.
Discussion: A notable exception to this are mutations located in G190 position: G190S and G190A both have reduced replication efficiency relative to wild-type and K103N-mutants.


  HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.
 PMID: 34377002       2021       Infection and drug resistance
Table: G190A/S
Discussion: V106I/M, K103N/Q, G190A/S, and Y181C were the major NNRTI-associated mutations, similar to those in other cities in China and other countries, and showed broad-spectrum resistance possibly caused by the wide use of NNRTIs.


  High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat.
 PMID: 34025122       2021       Infectious diseases
Table: G190A



Browser Board

 Co-occurred Entities




   Filtrator